Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment

Abstract Background Multiple sclerosis (MS) patients often suffer from gait impairment and fampridine is indicated to medically improve walking ability in this population. Patient characteristics, healthcare resource use, and costs of MS patients on fampridine treatment for 12 months in Germany were...

Full description

Bibliographic Details
Main Authors: Tjalf Ziemssen, Christine Prosser, Jennifer Scarlet Haas, Andrew Lee, Sebastian Braun, Pamela Landsman-Blumberg, Angela Kempel, Erika Gleißner, Sarita Patel, Ming-Yi Huang
Format: Article
Language:English
Published: BMC 2017-03-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Claims data
Germany
Fampridine
Online Access:http://link.springer.com/article/10.1186/s12883-017-0844-z

Internet

http://link.springer.com/article/10.1186/s12883-017-0844-z

Similar Items